A groundbreaking artificial intelligence platform designed to transform hypertension management worldwide launched on March 14, 2026. The innovative system, named Dr. PAI (Personalized AI Doctor), represents a significant advancement in chronic disease care by offering continuous, personalized monitoring and treatment guidance.
Developed through a collaboration between the Hong Kong Institute of Medical Engineering, Guangdong Medical University, and several prominent medical organizations including the Chinese Hypertension League, the platform integrates cutting-edge technology with medical expertise. Dr. PAI combines wearable blood pressure monitoring technology—specifically through a finger ring device—with AI doctor avatars and Large Language Models to create a comprehensive health management ecosystem.
The platform’s launch date coincided with Pi Day (3/14), symbolizing its data-driven approach to healthcare. This strategic timing underscores the system’s foundation in mathematical precision and continuous data analysis for managing hypertension, often called the ‘silent killer’ due to its frequently asymptomatic nature.
Medical experts emphasize the critical need for such innovation. “The danger of hypertension lies in its potential to become a ‘silent killer’ due to lack of management and awareness,” noted Professor Liu Lisheng, founding president of the Chinese Hypertension League and former World Hypertension League president. He highlighted that Dr. PAI makes early detection, prediction, prevention, diagnosis, intervention, and rehabilitation accessible to patients everywhere.
Dr. Sun Ningling, Chair of the Hypertension Branch of CPAM, explained that the platform addresses a fundamental gap in hypertension care: “Many patients lack continuous, professional, and accessible health guidance rather than the will to seek treatment.”
The system incorporates an extensive medical knowledge base containing thousands of hypertension screening and prevention questions. Its AI avatars integrate diagnostic logic, risk identification principles, and standardized treatment processes derived from leading medical experts.
With applications ranging from community medical services to home-based elderly care, Dr. PAI represents a potential paradigm shift in chronic disease management. Researchers anticipate the platform will play an increasingly vital role in preventing and treating hypertension and other chronic conditions globally.